Advertisement
Screener

CYTEK BIOSCIENCES, INC. (CTKB) Capital Expenditures Incurred but Not yet Paid

2.0 / 5 stars · 16/40 Roast Me

CYTEK BIOSCIENCES, INC. Capital Expenditures Incurred but Not yet Paid

CYTEK BIOSCIENCES, INC. (CTKB) reported Capital Expenditures Incurred but Not yet Paid of $605.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-05

  • CYTEK BIOSCIENCES, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$703.00K.
  • CYTEK BIOSCIENCES, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $1.31M, a 458.97% increase year-over-year.
  • CYTEK BIOSCIENCES, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $44.00K, a 43.59% decline year-over-year.
  • CYTEK BIOSCIENCES, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $45.00K.
  • CYTEK BIOSCIENCES, INC. capital expenditures incurred but not yet paid for fiscal 2025 was $129.00K, a 27.12% decline from fiscal 2024.
  • CYTEK BIOSCIENCES, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $177.00K, a 342.50% increase from fiscal 2023.
  • CYTEK BIOSCIENCES, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $40.00K, a 40.30% decline from fiscal 2022.
  • CYTEK BIOSCIENCES, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $67.00K, a 50.00% decline from fiscal 2021.
Period endCapital Expenditures Incurred but Not yet Paid 3 monthCapital Expenditures Incurred but Not yet Paid 6 monthCapital Expenditures Incurred but Not yet Paid 9 monthCapital Expenditures Incurred but Not yet Paid 12 month
2026-06-30-$703.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$605.00K
10-Q · filed 2026-08-05
$649.00K
derived: sum of 3 quarters · filed 2026-08-05
$694.00K
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$1.31M
10-Q · filed 2026-05-07
$1.35M
derived: sum of 2 quarters · filed 2026-05-07
$1.40M
derived: sum of 3 quarters · filed 2026-05-07
$1.20M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$44.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$89.00K
derived: sum of 2 quarters · filed 2026-02-26
-$105.00K
derived: sum of 3 quarters · filed 2026-08-05
$129.00K
10-K · filed 2026-02-26
2025-09-30$45.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$149.00K
derived: sum of 2 quarters · filed 2026-08-05
$85.00K
10-Q · filed 2025-11-05
$163.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30-$194.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$40.00K
10-Q · filed 2026-08-05
$118.00K
derived: sum of 3 quarters · filed 2026-08-05
$94.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$234.00K
10-Q · filed 2026-05-07
$312.00K
derived: sum of 2 quarters · filed 2026-05-07
$288.00K
derived: sum of 3 quarters · filed 2026-05-07
$123.00K
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$78.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$54.00K
derived: sum of 2 quarters · filed 2026-02-26
-$111.00K
derived: sum of 3 quarters · filed 2026-02-26
$177.00K
10-K · filed 2026-02-26
2024-09-30-$24.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$189.00K
derived: sum of 2 quarters · filed 2025-11-05
$99.00K
10-Q · filed 2025-11-05
$43.00K
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$165.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$123.00K
10-Q · filed 2025-08-06
$67.00K
derived: sum of 3 quarters · filed 2026-02-26
$133.00K
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$288.00K
10-Q · filed 2025-05-08
$232.00K
derived: sum of 2 quarters · filed 2026-02-26
$298.00K
derived: sum of 3 quarters · filed 2026-02-26
$189.00K
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$56.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$10.00K
derived: sum of 2 quarters · filed 2026-02-26
-$99.00K
derived: sum of 3 quarters · filed 2026-02-26
$40.00K
10-K · filed 2026-02-26
2023-09-30$66.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$43.00K
derived: sum of 2 quarters · filed 2024-11-07
$96.00K
10-Q · filed 2024-11-07
-$72.00K
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30-$109.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$30.00K
10-Q · filed 2024-08-06
-$138.00K
derived: sum of 3 quarters · filed 2025-02-28
-$154.00K
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31$139.00K
10-Q · filed 2024-05-08
-$29.00K
derived: sum of 2 quarters · filed 2025-02-28
-$45.00K
derived: sum of 3 quarters · filed 2025-02-28
-$22.00K
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31-$168.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
-$184.00K
derived: sum of 2 quarters · filed 2025-02-28
-$161.00K
derived: sum of 3 quarters · filed 2025-02-28
$67.00K
10-K · filed 2025-02-28
2022-09-30-$16.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
$7.00K
derived: sum of 2 quarters · filed 2023-11-14
$235.00K
10-Q · filed 2023-11-14
$60.00K
derived: sum of 4 quarters · filed 2024-03-13
2022-06-30$23.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$251.00K
10-Q · filed 2023-08-08
$76.00K
derived: sum of 3 quarters · filed 2024-03-13
$47.00K
derived: sum of 4 quarters · filed 2024-03-13
2022-03-31$228.00K
10-Q · filed 2023-05-09
$53.00K
derived: sum of 2 quarters · filed 2024-03-13
$24.00K
derived: sum of 3 quarters · filed 2024-03-13
2021-12-31-$175.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13
-$204.00K
derived: sum of 2 quarters · filed 2024-03-13
$134.00K
10-K · filed 2024-03-13
2021-09-30-$29.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$309.00K
10-Q · filed 2022-11-09
2021-06-30$338.00K
10-Q · filed 2022-08-10
2020-12-31$0.00
10-K · filed 2023-03-01
2020-06-30$11.00K
10-Q · filed 2021-09-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B